17.2.2017 – Our new article on insulins NPH, glargine, and detemir, and risk of severe hypoglycemia has been published in Annals of Medicine. The comparative safety of modern basal insulins regarding hypoglycemia among the working-age population has been unclear. Large reductions in the incidence of severe hypoglycemia were seen among real-life patients who started insulin detemir, as compared to patients who initiated glargine or especially NPH insulin. Given the large amount of patients using insulin, these findings may have considerable clinical consequences at the population level.
Insulins NPH, glargine, and detemir, and risk of severe hypoglycemia among working-age adults. Published in Annals of Medicine, doi: 10.1080/07853890.2016.1278302. – Available for a limited time: Full article